Zip, I'm not saying there isn't efficacy in adding Vascepa to cancer treatments. Hell, it seems that EPA is effective in virtually any inflammatory condition. But to somehow claim that Denner figured this out, and he will take advantage of it, when prior management did nothing, is absurd.
And also, this requires trials, FDA approval, etc. to use this as an indication. As an adjunct to cancer treatment, this is years away, if ever.
It just feels like we get way ahead of ourselves with the whole notion that Denner is figuring everything out that prior management didn't, and that Vascepa is the miracle cure for all medical conditions.
Right now, we can only confirm that Denner and team are continuing the same course as prior management...GIA until they roll out enough of EU and RoW to sell the company.
Market Data 
Markets 
AI
